Study of Hypoglycemic Activity of Novel 9-N-alkyltetrahydroberberine Derivatives.
Ontology highlight
ABSTRACT: Novel 9-N-alkyltetrahydroberberine derivatives were synthesized, among which, based on the results of OGTT, one compound containing the longest aliphatic substituent was selected for study in mice C57BL/6Ay, which demonstrate obesity, impaired glucose tolerance, and concomitant liver non-alcoholic fatty disease. Administration of this substance at a dose of 15 mg/kg for four weeks improved the insulin sensitivity of mice, which resulted in a decrease in fasting glucose levels and improved the tolerance of mice to OGTT glucose loading. A decrease in the level of lactate in the blood and a decrease in the amount of glucokinase in the liver were also found. The introduction of compound 3c did not have a toxic effect on animals based on biochemical data, histological analysis, and m
SUBMITTER: Khvostov MV
PROVIDER: S-EPMC9698964 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA